ZNF839 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.12389997308782E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.566500E-04 |
Normal-vs-Stage2 |
8.22249999999913E-05 |
Normal-vs-Stage3 |
3.31360050509488E-10 |
Normal-vs-Stage4 |
1.63535851527286E-12 |
Stage1-vs-Stage2 |
4.373500E-02 |
Stage1-vs-Stage3 |
3.87940000000642E-05 |
Stage1-vs-Stage4 |
1.6155999871259E-09 |
Stage2-vs-Stage3 |
3.172200E-01 |
Stage2-vs-Stage4 |
2.424300E-02 |
Stage3-vs-Stage4 |
1.286620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.97240002108856E-11 |
Normal-vs-AfricanAmerican |
8.557600E-01 |
Normal-vs-Asian |
7.581400E-01 |
Caucasian-vs-AfricanAmerican |
3.020200E-04 |
Caucasian-vs-Asian |
2.382300E-02 |
AfricanAmerican-vs-Asian |
7.237000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.39630579005279E-12 |
Normal-vs-Female |
9.244400E-04 |
Male-vs-Female |
2.795100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.472270E-02 |
Normal-vs-Age(41-60Yrs) |
1.09010000004517E-06 |
Normal-vs-Age(61-80Yrs) |
2.11479944667303E-10 |
Normal-vs-Age(81-100Yrs) |
3.827600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.717400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.476600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.318800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.999800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.856800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.551600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.976220E-02 |
Normal-vs-Grade 2 |
2.950300E-04 |
Normal-vs-Grade 3 |
1.12799991569545E-10 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.023120E-04 |
Grade 1-vs-Grade 3 |
4.57940000364587E-08 |
Grade 1-vs-Grade 4 |
1.48681067457801E-12 |
Grade 2-vs-Grade 3 |
1.420060E-03 |
Grade 2-vs-Grade 4 |
2.50910403565285E-11 |
Grade 3-vs-Grade 4 |
7.56070000000886E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.855340E-03 |
Normal-vs-ccB subtype |
3.1863400806742E-14 |
ccA subtype-vs-ccB subtype |
3.00889999582665E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.932100002211E-08 |
Normal-vs-N1 |
1.86339832453086E-11 |
N0-vs-N1 |
1.227980E-04 |
|
|